← FDA Drug Approvals (Drugs@FDA)
POSLUMA
NDA · New Drug Application · Sponsor: BLUE EARTH · Approved 2023-05-25
Drug application
- FDA Application #
NDA216023
- Application type
- New Drug Application
- Brand name
- POSLUMA
- Generic name
- FLOTUFOLASTAT F-18
- Active ingredients
- FLOTUFOLASTAT F-18 GALLIUM
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- BLUE EARTH
- Manufacturer
- Blue Earth Diagnostics
- First approval
- 2023-05-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown